Document Detail


Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
MedLine Citation:
PMID:  7734098     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this study was to compare the renal effects of angiotensin converting enzyme (ACE) inhibition with calcium channel blockade in a model combining genetic hypertension with diabetes. Streptozotocin diabetes was induced in spontaneously hypertensive rats (SHR). The animals were then randomized to receive no treatment, the ACE inhibitor, perindopril, or the dihydropyridine calcium antagonist lacidipine. Body weight, systolic blood pressure, glycemic control, renal function, and albumin excretion rate (AER) were assessed serially over the 32-week study period. At week 32 the animals were killed and glomerular volume was measured. Both antihypertensive regimens significantly reduced systolic blood pressure in diabetic SHR. There was no significant difference in glycemic control, serum creatinine, or glomerular filtration rate among the three groups at week 32. The ACE inhibitor perindopril significantly reduced AER and glomerular hypertrophy over the 32 weeks, whereas the calcium antagonist lacidipine failed to reduce AER or glomerular hypertrophy. Thus, in contrast to the effects of ACE inhibition, calcium channel blockade with lacidipine, despite significantly reducing blood pressure, failed to reduce renal injury in this model. These results support the hypothesis that antihypertensive regimens may differ in their capacity to protect the diabetic kidney, despite similar effects on systemic blood pressure.
Authors:
J R Rumble; A E Doyle; M E Cooper
Related Documents :
2663228 - The captopril tests: a new concept in detecting renovascular hypertension?
3034018 - Comparative double-blind study of ramipril and captopril in mild to moderate essential ...
2645758 - Angiotensin-converting enzyme inhibitors in the elderly.
17617778 - Treating patients for cardiovascular protection: combination therapy to achieve complet...
19942548 - Ureteral motility.
7174698 - Toward a non-traumatic determination of the rheological properties of the vascular wall.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  American journal of hypertension     Volume:  8     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  1995 Jan 
Date Detail:
Created Date:  1995-06-08     Completed Date:  1995-06-08     Revised Date:  2009-02-24    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  53-7     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Melbourne, Heidelberg Repatriation/Austin Hospitals, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Albuminuria / metabolism
Animals
Blood Glucose / drug effects
Blood Pressure / drug effects
Body Weight
Diabetes Mellitus, Experimental / complications,  drug therapy*,  physiopathology
Dihydropyridines / pharmacology*
Disease Models, Animal
Hypertension / complications,  drug therapy*,  physiopathology
Indoles / pharmacology*
Kidney Diseases / drug therapy*,  etiology,  physiopathology
Male
Perindopril
Random Allocation
Rats
Rats, Inbred SHR
Renin / blood,  drug effects
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Dihydropyridines; 0/Indoles; 103890-78-4/lacidipine; 82834-16-0/Perindopril; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, tr...
Next Document:  In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.